Bioplastics vs. the Green Premium: Can Legislation Close the Cost Gap?

 

 

 

Bioplastics are sustainable plastic materials derived from renewable biomass sources, and have now been commercialized for over two decades. So-called "drop-in" bioplastics such as bio-based polyethylene, polypropylene and PET provide identical properties to their fossil-based equivalents with a lower carbon footprint, whereas alternative bioplastics such as polylactic acid (PLA) and polyhydroxyalkanoates (PHAs) are fully biodegradable. Bioplastics therefore provide a more sustainable means of meeting the world's ever-growing demand for virgin plastic.

 

However, bioplastics still need to overcome the green premium. The IDTechEx research report "Bioplastics 2026-2036: Technology, Market, Players, and Forecasts" shows that both alternative and drop-in bioplastics are up to 5.8x more expensive than fossil-based plastics, with the lower cost of crude oil relative to biomass feedstocks a key factor.

 

 

 

 

While volatile petrochemical prices resulting from ongoing geopolitical volatility in 2026 do provide a market opportunity for bioplastics, they are not a silver bullet. The bioplastics industry is not immune to oil price spikes, with IDTechEx research showing that European PLA prices initially rose by up to 37% following the closure of the Strait of Hormuz in March 2026 due to higher energy and fertiliser costs. Furthermore, oil price-spikes are historically short-lived, while future slumps in the price of crude oil that damage the bioplastic industry's ability to compete on price remain possible. Supportive legislation is therefore needed to secure sustained long-term global demand for bioplastics.

 

 

The higher price of bioplastics means that regulatory support is generally required to increase their uptake. Support from legislators is largely the result of growing public pressure to mitigate the well-documented environmental challenges associated with conventional plastics, with a particular focus on deploying biodegradable bioplastics in single-use applications such as packaging, cups and cutlery. Consequently, a number of initiatives have now been introduced at a national level in many regions worldwide.

 

 

 

 

While bioplastics have received limited federal support in the USA, states including California and New Jersey have exempted compostable bioplastics from bans on single-use plastic bags. Further state-level support has come from the introduction of Extended Product Responsibility (EPR) legislation for plastic packaging. However, US EPR laws have largely focused on higher plastic recycling rates rather than explicitly supporting bioplastics. This lack of regulatory support has hindered the US bioplastics industry: IDTechEx research shows the USA produces over 50% less than both Europe and Asia Pacific in 2026, while major capacity expansions by players such as Danimer have been delayed due to challenging market conditions.

 

 

Conversely, China has delivered significant state support for bioplastics, with China's PLA industry expanding rapidly since the exemption of PLA from a nationwide ban on single-use plastic bags in 2020. However, IDTechEx research shows that China's PLA industry has now developed a production overcapacity as it has grown to account for ~50% of global PLA production. This has notably supressed PLA prices and reduced profit margins for PLA players both in China and globally, resulting in some planned Chinese capacity expansions being delayed as well as calls from US PLA player NatureWorks for the introduction of US import tariffs on Chinese PLA.

 

 

 

Moving forward, the bioplastics industry has recently received a promising new growth signal in the EU. The Packaging and Packaging Waste Regulation (PPWR) will be enforced from August 2026, which exempts compostable plastics from minimum recycled content targets for plastic packaging.

 

Furthermore, in April 2026 a European Commission report strongly recommended the integration of legally binding bio-based content targets within a revised PPWR. IDTechEx believes this development is particularly significant as legislative support for bioplastics has historically revolved around their biodegradability rather than their renewable sourcing, therefore excluding bio-based drop-ins. Conversely, this recommendation for the phased introduction of bio-based content targets of up to 44% by 2040 is inclusive of all bioplastics.

 

While the report's recommendations are yet to be adopted, their implementation would provide a significant new market driver for the European bioplastics industry. IDTechEx notes that growing European legislative support for bioplastics stems partially from the strategic importance of decoupling European supply chains from fossil fuel imports.

 

 

 

The IDTechEx report "Bioplastics 2026-2036: Technology, Market, Players, and Forecasts" provides detailed coverage and analysis of key legislative developments driving the growth of the bioplastics industry, as well as in depth evaluations of emerging bioplastic technologies, commercial applications and updates from key players. The report provides granular 10-year market forecasts for 14 synthetic and naturally occurring bioplastics, with key conclusions regarding technology readiness levels, market disruption potential and future growth drivers provided in each case.

 

For more information on this report, including downloadable sample pages, please visit www.IDTechEx.com/Bioplastics. For the full portfolio of materials and sustainability-related research, please visit www.IDTechEx.com.

 

IDTechEx guides your strategic business decisions through its Research, Subscription and Consultancy products, helping you profit from emerging technologies. For more information, contact research@IDTechEx.com or visit www.IDTechEx.com.